miR-126 as a Therapeutic Agent for Diabetes Mellitus

E-ISSN： 1873-4286|23|22|3309-3314

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.22, 2017-09, pp. : 3309-3314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

miR-210: a therapeutic target in cancer

By Hong Liu Han Yu Zhang Hongwei Zhao Qingchuan Qiao Yuan

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 21-28

Informa Healthcare

Access to resources Recommend Favorite

Insulin Glargine: A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus

By McKeage K. Goa K.L.

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1599-1624

Adis International

Access to resources Recommend Favorite

MicroRNA miR-122 as a Therapeutic Target for Oligonucleotides and Small Molecules

Current Medicinal Chemistry, Vol. 20, Iss. 29, 2013-09 ,pp. : 3629-3640

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic approaches to Type 2 diabetes mellitus

By Rose M.L. Paulik M.A. Lenhard J.M.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 9, 1999-09 ,pp. : 1223-1236

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Targets for the Prevention of Type 1 Diabetes Mellitus

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 227-236

Bentham Science Publishers

Access to resources Recommend Favorite